#Eli Lilly — FinScans

📈 Stocks

Investors Favor Eli Lilly Over Novo Nordisk After Downbeat Diagnosis

August 7, 2026 (14 days ago)

Investor sentiment turns bearish on Novo Nordisk while Eli Lilly gains favor amid shifting dynamics in the obesity-drug market.

LLY NVO

🌍 GLOBAL Read More →

📈 Stocks

Eli Lilly-Backed Scribe Therapeutics Soars 50% After Upsized IPO

July 24, 2026 (27 days ago)

Eli Lilly-backed biotech Scribe Therapeutics jumps 50% after upsized IPO, signaling renewed biotech IPO momentum.

SCRI LLY

🌍 US Read More →

📈 Stocks

Scribe Raises $128.7M in Upsized IPO Backed by Eli Lilly

July 24, 2026 (28 days ago)

Scribe Therapeutics, backed by Eli Lilly, raised $128.7 million in an upsized IPO, reflecting strong investor demand for biotech firms with major…

SCRIBE LLY

🌍 US Read More →

📈 Stocks

Eli Lilly-backed Scribe Therapeutics files for $107.2 million IPO

July 20, 2026 (31 days ago)

Scribe Therapeutics, with Eli Lilly’s backing, files for a $107.2 million IPO, highlighting gene-editing sector momentum and potential biotech IPO revival.

LLY

🌍 US Read More →

📈 Stocks

Novo, Lilly Brace for Ozempic Patent Expirations, Seek Next Blockbuster

May 28, 2026 (85 days ago)

Novo Nordisk and Eli Lilly stocks come under scrutiny as impending Ozempic and Mounjaro patent expirations threaten the GLP-1 revenue stream, forcing…

NVO LLY

Eli Lilly Loses Supreme Court Bid, Faces $194 Million Medicaid Payment

May 18, 2026 (94 days ago)

The Supreme Court rebuffed Eli Lilly's appeal of a $194 million Medicaid overpayment award, delivering a legal setback that threatens near-term earnings…

LLY XLV

🌍 US Read More →